Stockscreener 앱 받기
6.60
2.00%
-0.135
시간 외 거래:
6.65
0.05
+0.76%
전일 마감가:
$6.735
열려 있는:
$6.71
하루 거래량:
49,842
Relative Volume:
0.33
시가총액:
$57.23M
수익:
$137.27M
순이익/손실:
$-123.57M
주가수익비율:
-0.6027
EPS:
-10.95
순현금흐름:
$-102.89M
1주 성능:
-7.17%
1개월 성능:
+70.10%
6개월 성능:
+7.84%
1년 성능:
-44.84%
1일 변동 폭
$6.59
$7.00
1주일 범위
$6.59
$7.22
52주 변동 폭
$3.51
$16.95
Karyopharm Therapeutics Inc Stock (KPTI) Company Profile
명칭
Karyopharm Therapeutics Inc
전화
617-658-0600
주소
85 WELLS AVENUE, NEWTON, MA
KPTI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KPTI
Karyopharm Therapeutics Inc
|
6.60 | 58.40M | 137.27M | -123.57M | -102.89M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-07-11 | 재개 | H.C. Wainwright | Buy |
| 2023-01-19 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-09 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-11-19 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-08-06 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-08-06 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-07-02 | 개시 | Morgan Stanley | Overweight |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-01-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2019-07-23 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-07-05 | 재확인 | H.C. Wainwright | Buy |
| 2019-07-05 | 재확인 | Robert W. Baird | Outperform |
| 2019-03-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-02-28 | 재확인 | BofA/Merrill | Underperform |
| 2019-02-27 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-01-03 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2018-12-03 | 개시 | B. Riley FBR | Buy |
| 2018-11-09 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2018-05-24 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-04-02 | 재개 | Leerink Partners | Outperform |
| 2017-11-15 | 재개 | H.C. Wainwright | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2016-09-08 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-08-18 | 개시 | H.C. Wainwright | Buy |
| 2016-06-28 | 개시 | Robert W. Baird | Outperform |
모두보기
Karyopharm Therapeutics Inc 주식(KPTI)의 최신 뉴스
Will Karyopharm Therapeutics Inc. benefit from current market trendsMarket Weekly Review & Daily Stock Trend Reports - خودرو بانک
Can Karyopharm Therapeutics Inc. recover in the next quarterJuly 2025 Final Week & Daily Profit Focused Stock Screening - Newser
Is Karyopharm Therapeutics Inc. benefiting from innovation trendsJuly 2025 Trends & Free Community Supported Trade Ideas - خودرو بانک
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Karyopharm Therapeutics Inc. stock daily chart insights2025 Retail Activity & Low Drawdown Trading Techniques - Newser
What are Karyopharm Therapeutics Inc.’s recent SEC filings showingWeekly Profit Summary & AI Based Buy and Sell Signals - خودرو بانک
Is Karyopharm Therapeutics Inc. trending in predictive chart modelsMarket Risk Report & Fast Moving Stock Watchlists - Newser
What candlestick patterns are forming on Karyopharm Therapeutics Inc.Weekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Using data tools to time your Karyopharm Therapeutics Inc. exitJuly 2025 Setups & Weekly Watchlist for Hot Stocks - Newser
Is Karyopharm Therapeutics Inc. in a long term uptrendTrade Exit Report & Real-Time Volume Surge Alerts - خودرو بانک
Analyzing recovery setups for Karyopharm Therapeutics Inc. investorsWeekly Trend Summary & Community Consensus Stock Picks - Newser
Strategies to average down on Karyopharm Therapeutics Inc.Weekly Trend Recap & Free Risk Controlled Daily Trade Plans - Newser
Published on: 2025-09-04 06:44:04 - Newser
Published on: 2025-09-04 06:43:46 - Newser
Can Karyopharm Therapeutics Inc. hit a new high this month2025 Bull vs Bear & Stock Market Timing Techniques - Newser
Automated trading signals detected on Karyopharm Therapeutics Inc.2025 Price Targets & Reliable Breakout Stock Forecasts - Newser
Is Karyopharm Therapeutics Inc. gaining market shareCEO Change & Scalable Portfolio Growth Methods - خودرو بانک
Will Karyopharm Therapeutics Inc. benefit from rate cutsJuly 2025 News Drivers & Comprehensive Market Scan Reports - خودرو بانک
What machine learning models say about Karyopharm Therapeutics Inc.Trade Exit Summary & Weekly High Potential Alerts - Newser
Is now the right time to enter Karyopharm Therapeutics Inc.Weekly Risk Report & Fast Gain Swing Alerts - خودرو بانک
How to use a screener to detect Karyopharm Therapeutics Inc. breakoutsStock Surge & Free Technical Confirmation Trade Alerts - Newser
Karyopharm Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
What high frequency data says about Karyopharm Therapeutics Inc.Weekly Stock Recap & Accurate Entry/Exit Alerts - Newser
Can you recover from losses in Karyopharm Therapeutics Inc.July 2025 EndofMonth & Accurate Entry/Exit Alerts - Newser
Analyzing Karyopharm Therapeutics Inc. with multi timeframe chartsQuarterly Growth Report & Accurate Trade Setup Notifications - Newser
How Karyopharm Therapeutics Inc. stock reacts to Fed policy changesBull Run & Real-Time Volume Spike Alerts - Newser
Published on: 2025-09-01 11:39:57 - beatles.ru
What momentum shifts mean for Karyopharm Therapeutics Inc.2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - Newser
Forecasting Karyopharm Therapeutics Inc. price range with options dataMarket Volume Report & High Accuracy Trade Signal Alerts - Newser
How to read the order book for Karyopharm Therapeutics Inc.Market Sentiment Report & Reliable Price Action Trade Plans - Newser
Will Karyopharm Therapeutics Inc. stock go up soon2025 Risk Factors & Low Risk High Reward Ideas - Newser
Trend analysis for Karyopharm Therapeutics Inc. this weekJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Multi factor analysis applied to Karyopharm Therapeutics Inc.July 2025 Drop Watch & Daily Stock Trend Reports - Newser
Using AI based signals to follow Karyopharm Therapeutics Inc.Dividend Hike & Expert Approved Momentum Trade Ideas - Newser
Karyopharm Therapeutics Inc (KPTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Karyopharm Therapeutics Inc 주식 (KPTI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Poulton Stuart | EVP, Chief Development Officer |
Jul 29 '25 |
Sale |
4.37 |
191 |
835 |
27,223 |
| Abate Kristin | Chief Accounting Officer |
Jul 22 '25 |
Sale |
4.00 |
238 |
952 |
9,475 |
| Paulson Richard A. | President and CEO |
May 06 '25 |
Sale |
7.12 |
236 |
1,680 |
82,503 |
| Rangwala Reshma | EVP & Chief Medical Officer |
Apr 23 '25 |
Sale |
6.17 |
419 |
2,585 |
28,853 |
| Paulson Richard A. | President and CEO |
Apr 04 '25 |
Sale |
3.74 |
245 |
916 |
82,739 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer |
Mar 04 '25 |
Sale |
6.29 |
3,445 |
21,669 |
34,314 |
| Paulson Richard A. | President and CEO |
Mar 04 '25 |
Sale |
6.29 |
11,694 |
73,555 |
82,984 |
| Rangwala Reshma | EVP & Chief Medical Officer |
Mar 04 '25 |
Sale |
6.29 |
3,587 |
22,562 |
29,272 |
| Poulton Stuart | EVP, Chief Development Officer |
Mar 04 '25 |
Sale |
6.29 |
3,548 |
22,317 |
27,414 |
| Mano Michael | SVP, General Counsel&Secretary |
Mar 04 '25 |
Sale |
6.29 |
2,793 |
17,568 |
21,047 |
1.40%
자본화:
|
볼륨(24시간):